Literature DB >> 28853300

Enteroendocrine, Musashi 1 and neurogenin 3 cells in the large intestine of Thai and Norwegian patients with irritable bowel syndrome.

Magdy El-Salhy1,2,3, Tanisa Patcharatrakul4,5, Jan Gunnar Hatlebakk2,3, Trygve Hausken2,3,5, Odd Helge Gilja2,3,6, Sutep Gonlachanvit4,5.   

Abstract

OBJECTIVES: The prevalence, gender distribution and clinical presentation of IBS differ between Asian and Western countries. This study aimed at studying and comparing enteroendocrine, Musashi 1 (Msi 1) and neurogenin 3 (neurog 3) cells in Thai and Norwegian IBS patients.
MATERIAL AND METHODS: Thirty Thai and 61 Norwegian IBS patients as well as 20 Thai and 24 Norwegian controls were included. Biopsy samples were taken from each of the sigmoid colon and the rectum during a standard colonoscopy. The samples were immunostained for serotonin, peptide YY, oxyntomodulin, pancreatic polypeptide, somatostatin, Msi 1 and neurog 3. The densities of immunoreactive cells were determined with computerized image analysis.
RESULTS: The densities of several enteroendocrine cell types were altered in both the colon and rectum of both Thai and Norwegian IBS patients. Some of these changes were similar in Thai and Norwegian IBS patients, while others differed.
CONCLUSIONS: The findings of abnormal densities of the enteroendocrine cells in Thai patients support the notion that enteroendocrine cells are involved in the pathophysiology of IBS. The present observations highlight that IBS differs in Asian and Western countries, and show that the changes in large-intestine enteroendocrine cells in Thai and Norwegian IBS patients might be caused by different mechanisms.

Entities:  

Keywords:  Enteroendocrine cells; IBS; Musashi 1; immunohistochemistry; neurogenin 3; oxyntomodulin; peptide YY; serotonin; stem cells

Mesh:

Substances:

Year:  2017        PMID: 28853300     DOI: 10.1080/00365521.2017.1371793

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  6 in total

Review 1.  The role of diet in the pathophysiology and management of irritable bowel syndrome.

Authors:  Magdy El-Salhy; Tanisa Patcharatrakul; Sutep Gonlachanvit
Journal:  Indian J Gastroenterol       Date:  2021-03-05

2.  Overlapping of irritable bowel syndrome with erosive esophagitis and the performance of Rome criteria in diagnosing IBS in a clinical setting.

Authors:  Magdy El-Salhy; Odd Helge Gilja; Jan Gunnar Hatlebakk
Journal:  Mol Med Rep       Date:  2019-05-23       Impact factor: 2.952

Review 3.  Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones.

Authors:  Magdy El-Salhy; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  Nutrients       Date:  2019-08-07       Impact factor: 5.717

4.  Density of Musashi‑1‑positive stem cells in the stomach of patients with irritable bowel syndrome.

Authors:  Magdy El-Salhy; Trygve Hausken; Jan Gunnar Hatlebakk
Journal:  Mol Med Rep       Date:  2020-08-04       Impact factor: 2.952

5.  Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21st century.

Authors:  Magdy El-Salhy; Tanisa Patcharatrakul; Sutep Gonlachanvit
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

Review 6.  Possible role of intestinal stem cells in the pathophysiology of irritable bowel syndrome.

Authors:  Magdy El-Salhy
Journal:  World J Gastroenterol       Date:  2020-04-07       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.